Insider · CIK 0001774518

Chrousos Phaedra

Reports to the SEC for 1 company · WASHINGTON, DC

sec.gov

Transactions

Companies

Filings

CIK

0001774518

Forms 4 and 5

Insider transactions

16 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-04	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+41.6K sh	—	—	164,950
2025-06-05	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+59.2K sh	—	—	123,350
2024-05-22	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+21.9K sh	—	—	64,125
2024-05-22	VNDAVanda Pharmaceuticals Inc. · Stock Option (right to buy)A Award	Director	AAward	+40.2K sh	—	—	40,202
2023-06-08	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+17.3K sh	—	—	42,238
2023-06-08	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+34K sh	—	—	33,960
2022-06-16	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+12K sh	—	—	24,931
2022-06-16	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+24.7K sh	—	—	24,707
2021-06-14	VNDAVanda Pharmaceuticals Inc.S Sale	Director	SSale	−2,075 sh	$19.34	−$40.1K	12,925
2021-06-10	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	15,000
2021-06-10	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-11	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-06-11	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	10,000
2019-06-13	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2019-06-13	VNDAVanda Pharmaceuticals Inc.A Award	Director	AAward	+5,000 sh	—	—	5,000
2019-04-23	VNDAVanda Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000

Recent filings

Accepted (ET)
Jun 84
Chrousos Phaedra0001193125-26-261811
SEC(opens sec.gov)
Jun 94
Chrousos Phaedra0000950170-25-083889
SEC(opens sec.gov)
May 244
Chrousos Phaedra0000950170-24-064669
SEC(opens sec.gov)
Jun 124
Chrousos Phaedra0001209191-23-036275
SEC(opens sec.gov)
Jun 214
Chrousos Phaedra0001209191-22-038446
SEC(opens sec.gov)
Jun 154
Chrousos Phaedra0001209191-21-040615
SEC(opens sec.gov)
Jun 144
Chrousos Phaedra0001209191-21-040236
SEC(opens sec.gov)
Jun 154
Chrousos Phaedra0001209191-20-036780
SEC(opens sec.gov)
Jun 174
Chrousos Phaedra0001209191-19-037409
SEC(opens sec.gov)
Apr 244
Chrousos Phaedra0001209191-19-025783
SEC(opens sec.gov)

Companies

Vanda Pharmaceuticals Inc.DirectorVNDA

Address

C/O VANDA PHARMACEUTICALS INC. 2200 PENNSYLVANIA AVENUE, SUITE 300E

WASHINGTON, DC, 20037